The eye condition, which can induce the loss of central vision, could see effective treatment options pending FDA approval. Macular telangiectasia (MacTel) has long gone without a consensus treatment ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Macular telangiectasia type 2 is a progressive and ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Encelto is the first FDA-approved treatment for macular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results